Page last updated: 2024-08-23

substance p and Cryopyrin-Associated Periodic Syndromes

substance p has been researched along with Cryopyrin-Associated Periodic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, K; Liao, MF; Wang, J; Wang, XR; Yao, WL; Zhang, ZF	1

Other Studies

1 other study(ies) available for substance p and Cryopyrin-Associated Periodic Syndromes

Article	Year
Blocking PAR2 attenuates oxaliplatin-induced neuropathic pain via TRPV1 and releases of substance P and CGRP in superficial dorsal horn of spinal cord. Journal of the neurological sciences, 2015, May-15, Volume: 352, Issue:1-2 Topics: Animals; Calcitonin Gene-Related Peptide; Cryopyrin-Associated Periodic Syndromes; Disease Models, Animal; Male; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Wistar; Receptor, PAR-2; Signal Transduction; Spinal Cord Dorsal Horn; Substance P; Treatment Outcome; TRPV Cation Channels; Up-Regulation	2015

Article

Year

Blocking PAR2 attenuates oxaliplatin-induced neuropathic pain via TRPV1 and releases of substance P and CGRP in superficial dorsal horn of spinal cord.

Journal of the neurological sciences, 2015, May-15, Volume: 352, Issue:1-2

Topics: Animals; Calcitonin Gene-Related Peptide; Cryopyrin-Associated Periodic Syndromes; Disease Models, Animal; Male; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Wistar; Receptor, PAR-2; Signal Transduction; Spinal Cord Dorsal Horn; Substance P; Treatment Outcome; TRPV Cation Channels; Up-Regulation

2015